Workflow
Beijing (833429)
icon
Search documents
康比特:第六届董事会第二次会议决议公告
2023-08-29 09:18
一、会议召开和出席情况 (一)会议召开情况 证券代码:833429 证券简称:康比特 公告编号:2023-076 北京康比特体育科技股份有限公司 第六届董事会第二次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 1.会议召开时间:2023 年 8 月 26 日 2.会议召开地点:公司会议室 3.会议召开方式:现场和通讯 4.发出董事会会议通知的时间和方式:2023 年 8 月 16 日以书面方式发出 5.会议主持人:白厚增 6.会议列席人员:公司监事、高级管理人员 7.召开情况合法、合规、合章程性说明: 本次会议的召开符合《公司法》和《公司章程》的有关规定。 (二)会议出席情况 会议应出席董事 9 人,出席和授权出席董事 9 人。 二、议案审议情况 (一)审议通过《2023 年半年度报告及摘要》 1.议案内容: 公司 2023 年半年度报告及摘要的编制和保密程序符合法律、法规、公司章 程和公司管理制度的各项规定;本次半年度报告及摘要的内容和格式符合中国证 监会和北京证券交易所的各项规定,其 ...
康比特(833429) - 2023 Q2 - 季度财报
2023-08-28 16:00
Sports Events and Collaborations - In the first half of 2023, the company participated in multiple marathon events, providing high-quality professional sports nutrition and scientific services to runners[6]. - The company signed a strategic agreement with Xi'an Sports University in May 2023 to promote the development of industry-university-research collaboration based on digital sports technology achievements[7]. - The company developed a "Precision Dietary Nutrition Management System" in collaboration with a military medical center, aimed at digital nutrition management for military personnel[7]. - The company actively supported various sports events, including the 14th Beijing National Fitness Sports Festival and the 17th National College Bicycle Exchange Competition, from April to June 2023[7]. Financial Performance - The company's operating revenue for the current period is ¥373,868,636.68, representing a 22.26% increase compared to ¥305,795,060.44 in the same period last year[25]. - The net profit attributable to shareholders of the listed company is ¥45,011,158.07, reflecting a 53.87% increase from ¥29,252,813.13 in the previous year[25]. - The gross profit margin decreased to 40.16% from 43.34% year-on-year[25]. - Total assets increased by 7.53% to ¥1,072,583,945.37 from ¥997,468,500.09 at the end of the previous year[26]. - Total liabilities rose by 24.44% to ¥321,331,595.22 from ¥258,212,356.39 year-on-year[26]. - The net cash flow from operating activities is ¥49,797,982.45, an increase of 18.61% compared to ¥41,984,977.44 in the previous year[26]. - The basic earnings per share increased by 28.57% to ¥0.36 from ¥0.28 in the previous year[25]. Market Focus and Product Development - The company is focused on providing sports nutrition and health food products, as well as intelligent sports fitness solutions for various target groups[20]. - The company focuses on the whey protein and energy gel markets, enhancing product differentiation and competitive barriers[38]. - New high-quality ingredients and patented components were introduced to upgrade the whey protein product line, emphasizing clean labels and superior quality[38]. - The energy gel product line was expanded to meet both marathon event and daily training energy needs, including a new mint-flavored variant for summer[39]. - The company plans to increase R&D investment to improve military food products, including self-heating food orders, which saw significant year-on-year growth[40]. Risk Management and Internal Controls - The company emphasizes the importance of risk awareness regarding future plans and forecasts in its reports[11]. - Enhanced internal management processes were established to improve operational efficiency and ensure business effectiveness[42]. - The company has established a long-term supervision mechanism to strengthen the prevention of internal control risks[74]. - The company is committed to enhancing its internal control processes to adapt to its expanding business scale and market development[74]. Marketing and Sales Strategies - The company maintains a multi-channel marketing and sales model, focusing on both online and offline sales strategies[34]. - A stronger channel strategy was implemented to deepen partnerships with key clients and enhance customer support[41]. - The company is committed to brand marketing, emphasizing high-quality sports nutrition and leveraging various platforms for brand promotion[40]. Industry Trends and Market Potential - The global sports nutrition market size grew from $16.314 billion in 2017 to $18.56 billion in 2022, and is expected to reach $25.191 billion by 2026[46]. - The number of fitness enthusiasts in China reached 374 million in 2022, projected to grow to 464 million by 2027, indicating significant market potential[47]. - The sports nutrition industry is supported by national policies aimed at promoting health and wellness, enhancing market growth prospects[45]. - The company is focusing on digital transformation and integration of modern technologies in sports nutrition, aligning with national strategies[45]. Shareholder and Governance Information - As of June 30, 2023, the actual controller holds a total of 30.04% of the company's shares, with direct ownership of 5.67% and indirect control through related entities[73]. - The company has established a comprehensive governance structure to mitigate risks associated with the actual controller's influence on major decisions, including profit distribution and strategic direction[73]. - The company has a total of 9 board members and 3 supervisors, with a total of 3 senior management personnel[101]. Financial Management and Capital Structure - The company has maintained a consistent approach to capital management, with no significant changes in its capital structure reported[138]. - The total liabilities and equity at the end of the first half of 2023 amount to CNY 751,252,350.15, showing a balanced financial structure[137]. - The company has not reported any changes in minority interests, maintaining a consistent equity structure[138]. - The company has not issued any new shares or equity instruments during the reporting period, indicating a focus on internal growth[135]. Legal and Compliance Matters - The company has reported a total of 1,847,751.18 yuan in litigation and arbitration claims, which represents 0.25% of its net assets[79]. - There are no significant related party transactions or instances of shareholder fund misappropriation reported during the period[80]. - The company has not experienced any significant changes in major risks during the reporting period[75].
康比特(833429) - 2022 Q4 - 年度财报
2023-04-25 16:00
Strategic Partnerships and Recognition - In February 2022, the company partnered with JD Health to establish a "billion-yuan strategy" aimed at creating a market value of 100 billion yuan in the domestic sports nutrition industry[7]. - In March 2022, the company was recognized as a "Little Giant" enterprise in Beijing for its specialization and innovation[7]. - The company participated in drafting the first local quality management standard for sports nutrition food in China, officially released in June 2022[7]. - In June 2022, the company won the China Business Federation Science and Technology Award for key technologies in food bar design and emergency food manufacturing[7]. - The company has received various recognitions, including being a high-tech enterprise and a key cultivation enterprise in the Zhongguancun "Gazelle" program[52]. Financial Performance - The company reported a total revenue of 124.5 million yuan for the fiscal year 2022, marking a significant increase compared to the previous year[30]. - The company's operating revenue for 2022 was ¥635,055,782.19, representing a year-over-year increase of 29.72% compared to ¥489,571,531.43 in 2021[32]. - The net profit attributable to shareholders for 2022 was ¥57,613,654.83, up 26.90% from ¥45,400,186.54 in 2021[32]. - The total assets increased by 22.49% to ¥997,468,500.09 in 2022 from ¥814,301,508.30 in 2021[33]. - The company's debt-to-asset ratio decreased to 25.89% in 2022 from 32.00% in 2021, indicating improved financial stability[33]. - The gross profit margin for 2022 was 43.13%, slightly up from 42.93% in 2021[32]. - The weighted average return on equity increased to 9.78% in 2022 from 8.66% in 2021[33]. - The company reported a basic earnings per share of ¥0.54 for 2022, a 20.00% increase from ¥0.45 in 2021[32]. Market and Competition - The company faces market competition risks due to the increasing demand for sports nutrition products driven by the promotion of the "National Fitness" concept[15]. - The sports nutrition food industry in China is experiencing rapid growth, with significant market potential due to increasing health awareness among the public[57]. - The company has identified risks related to market competition as domestic and international brands enter the sports nutrition market[120]. Product Development and Innovation - The company is focused on developing sports nutrition and health food products, targeting competitive athletes and health-conscious consumers[25]. - The company is committed to providing scientific and intelligent sports fitness solutions, enhancing its market position in the nutrition sector[25]. - The company has a robust R&D process, including project initiation, small-scale testing, and pilot testing, ensuring product quality and feasibility[1]. - The company has successfully developed and launched a new line of ready-to-eat foods, including fried noodles and canned fish, expanding its product offerings[102]. - The company is focusing on optimizing production processes to enhance product quality and efficiency, thereby increasing production capacity[102]. Governance and Compliance - The company has established a comprehensive quality control system, ensuring product quality from raw material procurement to production[15]. - The company is committed to adapting to industry policy changes to mitigate risks associated with regulatory compliance[15]. - The company has established a comprehensive governance structure to prevent undue influence from the actual controller[117]. - The company has implemented measures to enhance internal controls and governance structures to mitigate operational risks[118]. Shareholder and Capital Management - The company completed a public offering that increased its share capital by 20.49 million shares on April 18, 2023[27]. - The actual controller holds a total of 30.01% of the company's shares, which poses a risk of influence over major decisions[14]. - The company has committed to not transferring or entrusting the management of shares held directly or indirectly for twelve months following the issuance[132]. - The company will disclose any major negative events or risks related to shareholding in its reduction plans[133]. Employee and Talent Management - The total number of employees increased from 613 to 670, with a net addition of 62 employees during the reporting period[192]. - The number of technical staff rose from 114 to 133, while production staff increased from 206 to 231[192]. - The company has implemented a competitive and incentive-based compensation and benefits system for employees, including social insurance and holiday benefits[194]. Risk Management - The company is committed to improving communication with consumers to address food safety concerns[119]. - The company has received ISO9001, HACCP, and export food enterprise certifications, but food safety risks cannot be completely isolated[15]. - The company has faced litigation with a total amount of 2,496,189.06 yuan, which accounts for 0.34% of the net assets at the end of the reporting period[125].
康比特(833429) - 2023 Q1 - 季度财报
2023-04-25 16:00
Financial Performance - Net profit attributable to shareholders for Q1 2023 was CNY 10,740,687.38, representing a growth of 4.88% year-on-year[10]. - Operating revenue for the first quarter of 2023 was CNY 130,890,335.62, up by 3.93% from the same period last year[10]. - The company's net profit attributable to shareholders for Q1 2023 was CNY 17,657,261.10, compared to a net loss of CNY 13,807,410.93 in Q1 2022, marking a significant turnaround[47]. - Operating revenue for Q1 2023 reached CNY 158,202,589.75, an increase of 31.8% from CNY 120,030,445.73 in Q1 2022[45]. - The total comprehensive income for Q1 2023 was CNY 17,657,261.10, compared to a total comprehensive loss of CNY 13,807,410.93 in Q1 2022[47]. - The company achieved a profit before tax of CNY 20,842,123.67 in Q1 2023, a substantial recovery from a loss before tax of CNY 16,047,526.88 in Q1 2022[46]. Assets and Liabilities - Total assets as of March 31, 2023, reached CNY 1,007,433,311.30, an increase of 1.00% compared to the end of 2022[10]. - The total liabilities to assets ratio (consolidated) was 25.55%, slightly down from 25.89% at the end of 2022[10]. - The company's total assets amounted to CNY 1,007,433,311.30, an increase from CNY 997,468,500.09 at the end of 2022, reflecting a growth of approximately 0.97%[33]. - The company's long-term borrowings increased to CNY 51,000,000.00 from CNY 36,000,000.00, indicating a rise of approximately 41.67%[34]. - The company's total current liabilities decreased to CNY 187,569,743.09 from CNY 202,081,471.14, a reduction of about 7.19%[34]. Cash Flow - The net cash flow from operating activities improved to -CNY 42,512,154.99, a 28.94% reduction in losses compared to Q1 2022[10]. - The net cash flow from operating activities for Q1 2023 was negative CNY 42,512,154.99, an improvement from negative CNY 59,823,927.27 in Q1 2022[49]. - Cash inflow from financing activities in Q1 2023 was CNY 20.10 million, an increase from CNY 6.00 million in Q1 2022, reflecting a growth of 235%[52]. - Cash outflow for investing activities in Q1 2023 totaled CNY 3.34 million, down from CNY 66.04 million in Q1 2022, showing a reduction of 94.9%[52]. - The ending cash and cash equivalents balance for Q1 2023 was CNY 200.02 million, compared to CNY 76.82 million in Q1 2022, marking an increase of 160.5%[52]. Shareholder Information - The total number of ordinary shares at the end of the reporting period was 124,500,000, with 62.39% being restricted shares[15]. - The top ten shareholders collectively held 64.08% of the shares, with the largest shareholder holding 22.53%[17]. Research and Development - Research and development expenses for Q1 2023 were ¥6,828,241.21, an increase from ¥4,378,889.93 in Q1 2022, reflecting a growth of approximately 55.9%[42]. - Research and development expenses increased to CNY 6,200,992.15 in Q1 2023, up from CNY 4,066,329.45 in Q1 2022, reflecting a focus on innovation[46]. Operational Stability - The company has no ongoing litigation or arbitration matters, ensuring a stable operational environment[24]. - The company has fulfilled all disclosed commitments without any overdue obligations during the reporting period[27].
康比特(833429) - 2022 Q4 - 年度业绩
2023-02-26 16:00
Financial Performance - The company achieved operating revenue of ¥636,994,552.03, a year-on-year increase of 30.11%[6] - Net profit attributable to shareholders reached ¥57,984,244.57, up 27.72% compared to the previous year[6] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥55,587,557.30, reflecting a 15.60% increase year-on-year[6] - Basic earnings per share increased to ¥0.56, representing a growth of 25.02% from the previous year[6] Assets and Equity - Total assets at the end of the reporting period were ¥999,169,087.01, a 22.70% increase from the beginning of the period[6] - Shareholders' equity attributable to the company increased to ¥739,868,927.08, up 33.58% from the beginning of the period[6] - The company's share capital rose to ¥124,500,000.00, marking a 19.70% increase[6] - The net asset value per share attributable to shareholders was ¥5.94, an increase of 11.59% year-on-year[6] Revenue Growth Drivers - The growth in revenue was driven by a focus on product strategy and a multi-channel sales approach, particularly in military supply business[7] - The increase in total assets and equity was influenced by profit growth and the completion of a public offering of shares to unspecified qualified investors[8]